newsfilter
← Latest News
GlobeNewswire·

Galera Adopts Limited Duration Stockholder Rights Agreement

MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (NASDAQ:GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the potential to